Oportuzumab Monatox-qqrs or Vicineum is a recombinant fusion protein designed to block protein synthesis and mediate tumor cell death by selectively targeting epithelial cell adhesion molecule (EpCAM)-expressing cells, which are commonly found in various solid tumors [32]. This evidence concerns the gene EPCAM and neoplasm.